(Q61967845)
Statements
A Phase II Study of the c-Met Inhibitor ARQ 197 in Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma (English)
0 references
November 2011
0 references
March 2014
0 references
16
0 references
18 year
0 references